Marco A. Rizzi

Attorney-at-law
LL.M.
Attorney at law Partner
Co-Head in International Practice
Office:
Languages: German English French Italian Spanish
VCard: Download
Download the profile as a PDF

Rizzi Marco

Vita

Marco's practice embraces all aspects of corporate and transactional work for privately held and stock-exchange listed companies. He also accompanies investors (particularly VCs), enterprises and founders from incorporation throughout the whole life-cicle of enterprises (mainly in the life sciences and technology sectors). Marco co-heads our firm's international practice and is highly experienceed in cross-border operations, investments and transactions. He furthermore regularly advises parties in connection with shareholders, transaction-related and commercial disputes. Described as "skilled negotiator", he is valued for his hands-on approach and multiculturality. Marco is very active in the International Bar Association (IBA), and participates in the organization of conferences like the IBA Global Entrepreneurship Conference and the IBA European Startup Conference.

Admitted to the Swiss Bar since 1994.
  • Partner with Bratschi Ltd. (since 2016)
  • Partner with Froriep, Zurich and Madrid (2005-2015)
  • Bär & Karrer, Zurich and Lugano (1999-2004)
  • Schürmann, Rausch und Rohrer, Zurich and Lugano (1994-1998)
  • Master of Laws (LL.M.), King's College London (2000)
  • University of Berne (1994)
  • Acted for Otto Group in the acquisition of a majority stake in Medgate Group by wayy of share purchase from Aevis Victoria SA and other parties and subscription of a dedicated capital increase, and in the acquisition of BetterDoc GmbH
  • Advised Asendia Holding AG and Asendia Press Edigroup SA in the acquisition of Dynapresse Marketing SA from 7Days Media Services GmbH
  • Acted for Bergé Auto (now Astara) in the acquisition of the Hyundai importer and distributor in Switzerland from Alcopa Group
  • Advised NASDAQ Stockholm listed Nederman Holding AB in the acquisition of Luwa Air Engineering AG from Gruenwald Equity Group
  • Acted for Milan stock-exchange listed Piquadro S.p.A. in the acquisition of Lancel International SA from SWX stock-exchange listed Groupe Richemont
  • Advised the shareholders of a new-economy Australian company in the merger (reverse acquisition) of a Swiss company with operations in Europe and Asia
  • Acted for SWX stock-exchange listed Therametrics Holding AG (renamed Relief Therapeutics Holding AG) in the business combination with Relief Therapeutics SA and the conversion of a convertible loan
  • Advised SWX stock-exchange listed Therametrics Holding AG in the divestiture and spin-off of its CRO activities in Italy, Germany and Rumania
  • Advised SWX stock-exchange listed Therametrics Holding AG in a capital increase and right offering
  • Acted for SWX stock-exchange listed mondo biotech holding AG (renamed into Therametrics Holding AG) in the business combination with Pierrel Research International S.p.A.
  • Advised Swiss biotech company Auris Medical Holding AG in its IPO on Nasdaq and in its pre-IPO business reorganization
  • Acted for Swiss biotech company Evolva AG in its series C pre-IPO investment round
  • IBA LPD Council (as from 2023)
  • IBA Closely Held and Growing Business Enterprises Committee, Chair (2019-2020)
  • AEHS (Asociación Económica Hispano Suiza, Madrid), member of the Board of Directors (2010-2016)
  • Swiss School Madrid (Colegio Suizo Madrid), President of the Board of Directors (2007-2010)
  • recommended for «Commercial, Corporate and M&A» by Legal500 (2023)
  • recommended for «Healthcare and Life Sciences» by Legal500 (2023)
  • highly recommended «Switzerland - Best Law Firms for M&A» by Leaders League (2023)
  • highly recommended «Switzerland - Best Law Firms for Capital Markets» by Leaders League (2023)
  • listed as «notable practitioner» for «M&A» by IFLR1000 (2022)
  • recommended for «Leading Firms: German-Speaking Switzerland» by Legal500 (2022)
  • recommended for «Commercial, Corporate and M&A» by Legal500 (2022)
  • recommended for «Healthcare and Life Sciences» by Legal500 (2022)
  • highly recommended «Switzerland - Best Law Firms for M&A» by Leaders League (2022)
  • highly recommended «Switzerland - Best Law Firms for Capital Markets» by Leaders League (2022)
  • listed as «notable practitioner» for «M&A» by IFLR1000 (2021)
  • recommended for «Employment» by Legal500 (2021)
  • recommended for «Leading Firms: German-Speaking Switzerland» by Legal500 (2021)
  • highly recommended «Switzerland - Best Law Firms: Capital Markets» by Leaders League (2021)
  • highly recommended «Switzerland - Best Law Firms for Corporate / M&A» by Leaders League (2021)
  • recommended for «Banking and finance», «Capital markets», «Employment» and «Leading firms: German-speaking Switzerland» by Legal500 (2019)
  • «Foreign expert for Spain in Corporate/M&A» by Chambers Global (since 2016)
  • «Foreign expert for Italy in Corporate/M&A» by Chambers Global (2017)
  • recommended for «Commercial, Corporate and M&A» by Legal500 (2016)
  • Swiss Bar Association
  • Zurich Bar Association
  • IBA (International Bar Association)

More from Marco A. Rizzi

Know-how

Publication

Switzerland - Technology M&A 2020

Learn more
Publication

Switzerland - Technology M&A 2019

Learn more

News

24.03.2022

Otto Group Acquires a Majority Stake in the Medgate Group

Learn more

Our Offices

Contact form